Back to Search
Start Over
AUTOLOGOUS STEM CELL THERAPY FOR SINGLE RIGHT VENTRICULAR DYSFUNCTION AFTER FONTAN OPERATION: PHASE I SAFETY AND FEASIBILITY STUDY OF INTRACORONARY INFUSION OF BONE MARROW-DERIVED MONONUCLEAR CELLS
- Source :
- Journal of the American College of Cardiology. 75:563
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- The increased workload on single right ventricle (sRV) leads to increased risk of Fontan failure due to ventricular dysfunction. Conventional heart failure therapy has mixed results. This has led to increased interest in seeking alternative therapeutic strategies to improve ventricular function
- Subjects :
- medicine.medical_specialty
Ventricular function
business.industry
medicine.medical_treatment
Stem-cell therapy
medicine.disease
Peripheral blood mononuclear cell
Right ventricular dysfunction
medicine.anatomical_structure
Increased risk
Internal medicine
Heart failure
cardiovascular system
medicine
Cardiology
cardiovascular diseases
Fontan failure
Bone marrow
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 75
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........1c2f0065541bf6081158d66ae5fc595d
- Full Text :
- https://doi.org/10.1016/s0735-1097(20)31190-6